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Abstract
B lymphocytes are central players in the immune response; canonically, they have been 
recognized as precursors of antibody-producing cells: plasma cells. Recent findings have 
shown that the role of B lymphocytes goes far beyond the production of antibodies. There 
are different subtypes of B lymphocytes with different participations in innate and adap-
tive responses that include the recognition of the antigen, its processing, and its presenta-
tion to T lymphocytes, as well as the production of cytokines that impact and modulate 
the response toward the pathogen. Traditionally, it has been considered that B lympho-
cytes do not have phagocytic abilities that allow them to internalize, to process, or even 
to be infected by bacterial pathogens. The new information has shown that B lympho-
cytes can be readily infected by bacterial pathogens like Salmonella, Francisella, Moraxella, 
and Mycobacterium, among others, and respond to those infections. Some of the recent 
advances on these topics will be presented in this chapter.
Keywords: B lymphocyte, B1 lymphocytes, bacterial infection, Brucella, Salmonella, 
Mycobacterium, Francisella, endocytosis, macropinocytosis, innate response
1. Introduction
1.1. A brief history on the B-cell discovery
The immune response comprises cellular and humoral elements; among the cellular elements, 
macrophages were the first cells to be described by Metchnikoff in the year 1889 [1]. Almost 
simultaneously with Metchnikoff findings, began the recognition of one of the primordial 
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elements of the specific humoral response: the antibodies. Von Bering and Kitasato in 1880 
present their first work on serotherapy, showing that in the serum of animals immunized with 
diphtheria or tetanus toxins, there were specific elements of recognition for these toxins and 
that their use in patients conferred protection [2]. Later, Phlizalix and Calmette groups inde-
pendently produce antisera against snake venoms [3], confirming the relevance of specific 
serum elements for the protective response. In those days, histological studies on organs of 
experimental animals subjected to immunization processes suggested that lymphoid organs 
were sites likely responsible for the synthesis of the serum elements responsible for protec-
tion against toxins and poisons [4]. Tisselius and Kabat in the 1930s demonstrated by electro-
phoretic techniques that humoral elements responsible for the serological protective response 
against toxins and poisons belong to the serum gamma globulin fraction [5]. Some years later, 
in the 1940s, ex vivo culture of plasma cells from the spleen of hyperimmune animals was 
achieved, and it was observed that, even in culture, the plasma cells were still producing 
the specific antibodies [6]. Later, the development and application of fluorescence techniques 
allowed the identification of antibodies in situ, locating them closely with the plasma cells 
present in secondary lymphoid organs [4]. Nossal´s experiments demonstrated that antibod-
ies produced by plasma cells isolated from immunized animals retained biological activity in 
vitro against the bacteria used in the immunization [7]. Human immunodeficiency studies, 
like Bruton’s immunodeficiency, which is characterized by the absence of gamma globulin 
production and the absence of plasma cells in lymphoid organs [8, 9], demonstrated now in 
humans that antibodies were produced by plasma cells. The Landstainer and Chase experi-
ments excluded antibodies as mediators of cell-mediated hypersensitivity responses [10], and 
it is in the 1960s when observations on the development of the immune response in thymec-
tomized and reconstituted animals allowed to recognize the thymus as a fundamental organ 
of the immune response responsible for grafts rejection but also contributed to antibody pro-
duction [11, 12]. The bird model for study of elements of the immune response initiated the 
identification of the organ responsible for B-lymphocyte production [13], and in 1965, in birds, 
it was demonstrated that in the thymus and in the bursa, the two cellular lineages fundamen-
tal for the immune response are generated [14]. Almost simultaneously, and thanks to the 
use of radioactive labels, it was demonstrated that circulating lymphocytes stimulated with 
antigen were the precursors of antibody-producing cells [15, 16], and by the year 1969, the 
two populations of lymphocytes were identified as T lymphocytes for those thymic-depen-
dent, and those thymic-independent (bursa-equivalent) were referred as B lymphocytes [17]. 
Afterward, it was established in non-avian experimental models that a cooperative response 
of both lymphocyte species (T and B) was necessary for specific antibody production [18]; 
these observations prompted a large number of studies that recognized the complexity of T-B 
cooperation, resulting in specific responses to the antigen, including the production of specific 
high-affinity antibodies [19].
1.2. B lymphocytes: a bridge between innate and adaptive immune responses
It is now known that there are several types of B lymphocytes [20] and that B2 lymphocytes 
produce specific antibodies during the adaptive response [21]. On the other side, there are 
also natural antibodies of IgM class mainly [22]; unlike the adaptive antibodies, the natural 
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antibodies are produced by B1 lymphocytes [23]. B1 lymphocytes are subdivided into B1-a and 
B1-b—subtype B1-a is responsible for natural antibody production—respond to T-independent 
antigenic challenges, are located mainly in the peritoneal and pleural cavity, and represent 
the first line of defense against microbial challenges [24]. In addition, B1-a lymphocytes may 
internalize and eliminate bacterial pathogens and have CD11b marker [25], resembling a mac-
rophage phenotype. Some authors have suggested that the B1-a subset of lymphocytes and 
macrophages share lineage relationships, so these B/macrophage bi-phenotypic cells may rep-
resent an ancient B-lymphocyte lineage capable of adapting to bacterial challenges and innate 
responses [26]. The mammalian B1-a subset of lymphocytes could be evolutionary related to B 
cells from fishes, particularly teleost fishes like rainbow trout, catfish, etc.; circulating B cells in 
teleost fishes are morphologically similar to mammalian B lymphocytes; they also secrete and 
express immunoglobulin molecules at the membrane level with IgM, IgD, or IgT/Z isotypes 
and also possess phagocytic abilities [26]; this evolutionary theory of B cell supports the idea 
of an innate role of B1-a lymphocytes. In this context, B1-a lymphocytes and natural antibodies 
represent a bridge between innate and adaptive immunity [27].
2. B-cell subtypes
An important role of B lymphocytes in defense against pathogens is that B cells are part of 
a long-lived lymphocyte group that participates in the immune response by capturing and 
concentrating antigens for the presentation and production of antibodies. From the time that 
a B lineage cell becomes a mature B cell expressing the B-cell receptor (BCR) on its membrane, 
several transition steps have to occur [20]. During these steps, B cells are directed for negative 
and probably positive selection involved in generating a mature B-cell repertoire [28]. B lym-
phocytes have been divided into two subtypes, according to the origin of their development 
into B1 and B2 cells. B1 lymphocytes are the first cells produced in the ontogeny; in mice, B1 
cells are produced in the fetus and are derived from distinct precursors. B1 cells are different 
from B2 lymphocytes by their capacity of spontaneous antibody production, self-renewal, 
impossibility for clonal expansion, and low somatic hypermutation [29].
B2 cell precursors in the bone marrow give origin to B-cell populations of the marginal zone 
and the follicular zone; these B cells are the main populations that respond to antigen contact 
then forming the germinal centers and therefore are long-term responders. These cell popula-
tions are the majority B lymphocytes in the host and are predominant in all lymphoid tissues. 
Marginal zone (MZ) B lymphocytes in the mouse are restricted to the splenic marginal zone, 
while their human counterparts appear to be also in blood circulation. In the mouse B1 cells 
are divided in two subsets, B1-a and B1-b, based on their expression of CD5; B1a cells (CD5+) 
and B1-b cells (CD5−) appear to share developmental precursors. Apart from the differential 
expression of CD5, they are phenotypically similar, with few functional differences like the 
ability for internalizing bacterial pathogens [24, 30].
The main function of B1 lymphocytes is the production of large amounts of natural antibodies 
of the IgM isotype that responds to encapsulated bacterial infections (among others bacterial 
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challenges) and the production of IgA associated with mucosal defense against parasites. 
However, these cells are also able to produce IgG2 and IgG3 isotypes spontaneously, and 
under certain conditions, they may produce IgE. The production of antibodies by B1 lympho-
cytes is characterized by being spontaneous although it can be induced by T-cell-independent 
antigens and certain cytokines [31]. B1 lymphocytes predominate in fetal life but decrease 
with increasing age and have been reported to increase again in advanced age in mice as in 
humans. However, in the elderly, despite the increase, these cells are not fully functional, 
making older guests susceptible to acquire frequent lung infections associated with pneumo-
nia. The natural antibodies have low specificity, so they are able to recognize self-antigens; for 
this, B1 cells have been identified as potential participants in the development of autoimmune 
diseases. A high number of B1-a cells have been associated with autoimmunity in human and 
mouse models. In addition, a greater number of B1 cells have been reported in patients with 
systemic lupus erythematosus, Sjögren’s syndrome, and rheumatoid arthritis [32, 33].
B1 cells are the main population of B lymphocytes that are located in cavities such as the 
pleura and peritoneum (35–70%); these cells are mobilized between both cavities through 
the omentum, a process that requires the expression of the chemokine ligand CXCL13. In 
response to the pathogens, B1 cells are mobilized from their primary location within the peri-
toneum or pleura to secondary lymphoid organs such as the spleen and lymph nodes and 
at these sites begin to secrete IgM antibodies, so B1 lymphocytes represent a quick innate 
response toward bacterial challenges. B1 cells have been reported to be found in the spleen 
(1–2%), lymphoid nodes (0.1–0.3%), bone marrow (0.1–0.2%), lung parenchyma (0.4–0.6%), 
intestinal lamina propria (up to 50% are IgA + B cells), and blood (0.3–0.5%). In the peritoneal 
cavity, a subtype of B1 lymphocytes tend to lose expression of the CD43 molecule, but most 
of these cells in other tissues retain this marker; however, when B1 cells are activated, they 
overexpress CD43. In the peritoneal and pleura cavity, most of the B1-a and B1-b lymphocytes 
express the integrin CD11b but when these cells migrate to other organs such as the spleen 
downregulate its expression. In terms of functionality, B1 lymphocytes and marginal zone B 
cells are very similar; for this reason, the subgroup of marginal zone B cells (MZ) has been 
included in the group of “innate” type B cells, conformed then by B1-a cells, B1-b cells, and B 
cells of the marginal zone. B-cell MZ is also considered as B regulatory cell since after activa-
tion, it produces high levels of IL-10 (Figure 1) [34].
B1 lymphocytes in addition to producing the natural antibodies also actively contribute to the 
bacteria-induced immune response; several groups have explored B1 cell responses to patho-
gens like Streptococcus pneumoniae, Salmonella spp., Francisella spp., Borrelia hermsii, and influ-
enza virus, among others. The antibody response analyzed for each case showed an increase 
of IgM produced by B1 cells in the spleen, regional lymph nodes, or serum. Some studies 
support the idea of a heterogeneity of B1 cells, but the causes of this heterogeneity are largely 
unknown and poorly explored. However, Baumgarth has considered three factors that can 
modulate the functions of B1 cells: (1) the multiple origin of B1 cells, (2) tissue-specific signals, 
and (3) differences in exposure and responsiveness of B1 cells toward self and foreign anti-
gens. It has been suggested that it is important to determine the impact of these signals on the 
functionality of B1 cells, which could clarify much of the biology of this cell population and 
one of its most important products, the natural IgM [35].
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3. B-cell receptors involved in bacterial recognition and uptake
As referred earlier B lymphocytes are not only plasma cell precursors but a heterogenic sub-
set of cells with the capability to act as antigen-presenting cells (PCA) and produce pro- and 
anti-inflammatory cytokines. Some B-lymphocyte subsets are able, at different rates, to engulf 
several pathogens predominantly virus and bacteria; this event is mainly mediated by BCR, 
Toll-like receptors (TLR), and complement receptors (Figure 2). In some cases, after bacterial 
uptake, B lymphocytes are activated and settle a protective or suppressive immune response; 
also, they may act as pathogen niches or reservoirs that allow bacteria dissemination in the 
organism. The endocytic pathways developed by B lymphocytes that allow bacterial uptake 
depend on the receptors engaged during bacterial recognition. In other cases, bacterial com-
ponents itself trigger in the host cell, mechanisms that allow their entrance into the B cells 
(Figure 3).We will describe some of these elements.
3.1. B-cell receptors
The B-cell receptor (BCR) for antigen is a complex of membrane immunoglobulin (mIg) of 
isotype IgMhi and IGDlow in B1 and B2 lymphocytes and IgMhi and IgDlow/mid in B regulatory 
cells; this complex is responsible for extracellular antigen attachment and is linked to at least 
two other proteins, Ig α and Ig β forming a heterodimer. The mIg itself does not contain any 
Figure 1. Immunophenotype of mature B-cell subpopulations. The B2-cell population constitutes the majority of spleen 
B cells formed by follicular cells (FZ) and marginal zone B cells (MZ). B1-a and B1-b cells are smaller populations in 
terms of frequency in the spleen; they can be distinguished based on CD5 expression: B1-a (CD5+) cells and B1-b (CD5−) 
cells. It appears that regulatory B cells have phenotypic markers of B1 and B2 cells.
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signaling motifs, but instead the Igα/β heterodimer contains immunoreceptor tyrosine-based 
activation motifs (ITAMs) responsible for initiating the signaling after antigen binding [36]. 
Membrane Ig (mIg) differs from circulatory antibody in the C-terminus of the heavy chain 
[37]. B-cell activation is triggered by BCR-antigen interaction and leads to multiple cellular 
events as BCR-antigen complex internalization, the signalosome assembly, regulation of gene 
Figure 2. B-lymphocyte receptors involved in pathogens uptake. B lymphocytes displayed a wide number of receptors 
capable to recognize and engulf pathogens; they include intra- and extracellular innate receptors like TLRs, Dec-1, 
complement receptors, and the adaptive BCR receptor.
Figure 3. Endocytic pathways in B lymphocytes responsible for bacterial uptake. B lymphocytes are not only precursors 
of plasma cells but also a multitask cells. Several endocytic pathways may take place on the B cells to internalize bacterial 
pathogens; the cartoon depicts some of the pathways already described: clathrin-mediated endocytosis, Fc-mediated 
phagocytosis, CR (complement receptor)-mediated endocytosis, BCR-mediated endocytosis, TLR-mediated endocytosis, 
and macropinocytosis.
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expression, cytoskeleton reorganization, and plasma and long-live B memory cell generation. 
Antigens internalized through BCR are processed and presented on the major histocompat-
ibility complex II (MHC II). The idea that dimeric BCR complex binding the antigen was 
enough to activate B cells was accepted for years; nevertheless, it is known that B cells can 
form microclusters required for B-cell activation [38, 39], which involved around 10–100 BCR 
molecules; even in this microcluster, BCR complexes can interact in an oligomeric pattern [40]. 
Most of the studies related to antigen recognition by BCR have been related to soluble anti-
gens [41]; however, more evidences have demonstrated that BCR also recognizes complete 
pathogens, like Moraxella catarrhalis [42] and more recently Salmonella typhimurium [43].
3.2. Toll-like receptors (TLRs)
Toll-like receptors (TLRs) are a family of transmembrane and cytoplasmic receptors that are phy-
logenetically ancient that share homology with the IL-1 receptor; TLRs are part of the group 
of molecules responsible of pathogen´s recognition that collectively receive the name of patho-
gen recognition receptors (PRRs) and are expressed in dendritic cells, macrophages, and NK 
cells (innate immune cells); B and T lymphocytes (cells of the adaptive immunity); and epithelial 
cells, endothelial cells, and fibroblasts (nonimmune cells). TLRs are responsible for activating the 
innate immune response [44]. The ligands of the TLRs, known as pathogen-associated molecu-
lar patterns (PAMPs), are highly conserved microbial molecules or harmful endogenous factors 
[damage-associated molecular patterns (DAMPs)]. When B cells-TLRs bound to their ligands, 
several activation pathways are engaged; two of the most studied are TLR4 and TLR9 activation 
pathways; TLR4 is expressed on the B-cell membrane along with MD-2 molecule, and this het-
erodimer participates in lipopolysaccharide (LPS) recognition to initiate several intracellular sig-
naling pathways; one of the most important is the TIRAP-MyD88 pathway that regulates NF-κB 
activation and inflammatory cytokine production like IL-8, transforming growth factor alpha 
(TNF-α), etc. TLR9 is another important B cell-TLR, which is expressed in the endoplasmic reticu-
lum and is recruited to endosomal/lysosomal compartments after stimulation with CpG DNAs, 
activating the MyD88 pathway without TIRAP, culminating in NF-κB activation, and resulting in 
the production of proinflammatory cytokines [45]. TLRs are classified based on their localization 
as cell surface TLRs (TLR1, TLR2, TLR4, TLR5, TLR6, and TLR10) or intracellular TLRs (TLR3, 
TLR7, TLR8, TLR9, TLR11, TLR12, and TLR13); on humans 10 members of the TLR family have 
been described, while murine cells express 13 TLRs [44]. B lymphocytes express ten types of TLR 
(TLR1-10) [46–48]; their expression depends on B-cell tissue localization and the stage of B-cell 
activation. TLRs 3, 4, and 5 and 8 are absent in naive and memory B cells but are present in plasma 
cells; TLRs 6–9 are highly expressed in naïve B cells, but when they are activated, the intracellular 
TLR9 is the most highly expressed [45, 49]. Recently, some authors have demonstrated that TLR 
ligands have a modulatory effect on the B-lymphocyte response, for instance, lipopolysaccharide 
(LPS) and CpG-containing DNAs promote proliferation, class switching, and plasma differentia-
tion and are directly related with Th1 responses and autoimmune diseases [50–53]. Deficiencies 
in the downstream signaling pathways in B lymphocytes after TLRs activation favored pathogen 
infections specially the ones caused by S. pneumoniae, S. aureus, and P. aeruginosa [54]. TLR activa-
tion could be also detrimental for the B cells; for instance, B-lymphocyte TLR-2 interacting with 
Shigella flexneri promotes apoptosis of the host cell [55].




Dectin-1 (Dec-1) is a transmembrane C-type lectin-like receptor (CTLR) that binds β-glucans; it 
is expressed mainly in myeloid cells; when Dec-1 recognizes its ligand, the interaction induces 
B-cell activation with the participation of SYK, the MAPK ERK and JNK, and the transcription 
factors AP-1 and NF-κB, leading to the production of proinflammatory cytokine production (like 
IL-8) and arachidonic metabolites synthesis [56, 57]. Dec-1 binds to numerous pathogens through 
their specific ligands β-1,3 glucans, most frequent in fungi pathogens like Aspergillus, Candida, 
Coccidioides, and Pneumocystis and in nonpathogenic Penicillium and Saccharomyces; beside Dec-1 
can recognize mycobacteria [58]. Dec-1 was first described in dendritic cells; however, now it is 
known that Dec-1 is expressed in monocytes and lymphocytes. In B lymphocytes, Dec-1 activa-
tion leads to IL-8 production and neutrophil chemotaxis which shows that B lymphocytes can 
directly recognized pathogens via PRRs and have an important role in antifungal response [59].
3.4. Complement receptors
The complement system involves numerous plasma proteins that react with one another, in 
a cascade-like process that results in molecules that opsonize pathogens and promote inflam-
matory responses that help to fight infection. Complement proteins execute their biological 
functions by binding their corresponding receptors (CR1, CR3, and CR4) present in several 
cell types like macrophages, neutrophils, etc. B lymphocytes also express complement recep-
tors, like CD35 (CR1) and CD21 (CR2) [60]. CR1 binds C3b and C4b, while CR2 binds C3d. It 
is known that CR2 interacts with CD19; this complex acts as a co-receptor for BCR [61].
Complement receptors CR1 and CR2 are expressed differentially during B-human-lymphocyte 
development. CR1 is more expressed in memory cells than in naïve cells, while CR2 is low 
expressed in memory cells. Changes in CR expression on B lymphocytes are related with 
breaking of B-cell tolerance and increased susceptibility to bacterial infections [62]. CR partici-
pates in bacteria internalization; Francisella tularensis is engulfed by B lymphocytes through 
complement receptors [63].
3.5. Fc receptors
Fc receptors (FcRs) belong to the immunoglobulin superfamily; they are expressed in many 
immune cells as monocytes, mastocytes, NK cells, and B lymphocytes and recognize the cris-
talizable fragment of the immunoglobulins (Fc) [64]. FcR activation results in many relevant 
responses like cytotoxicity, phagocytosis, mast cell activation, and pathogen clearance. FcRs 
are classified according to the antibody isotype; they recognized FcRγ (IgG), FcRε (IgE), and 
FcRα (IgA) [65].
FcR activation regulates many B lymphocyte activities, like activation and proliferation, class 
switching, and maturation of naive cells into plasma cells [65, 66]. Alterations in FcR func-
tionality have been related to autoimmune diseases [67]. Some pathogens require immu-
noglobulin opsonization to be uptaken by B lymphocytes, coxsackievirus—opsonized with 
non-neutralizing antibodies infects and then replicates into B cells [68]. Bacterial pathogens 
like Brucella abortus require IgM opsonization to be internalized into B lymphocytes [69].
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3.6. Mechanisms of bacterial uptake exerted by B lymphocytes
3.6.1. Phagocytosis
Phagocytosis was first described by Mechnikoff in 1884 and as a whole is one of the most 
important defense mechanisms against pathogens [1]. B lymphocytes have been considered 
as non-phagocytic cells or with much less internalization capabilities than macrophages [70, 
71]. Still, it is a controversy upon the endocytic mechanism that the B lymphocyte exerts to 
internalize bacteria; it is not yet defined if internalization is by phagocytosis or by macropino-
cytosis (which is also known also as phagocytosis-like) or other mechanisms [72–74]. Recent 
evidence has shown that the B1-a lymphocyte subset can internalize pathogens [69, 75]; even 
some authors readily consider that B1-a lymphocytes are phagocytic [76]. However, still, it is 
not clear if bacterial recognition by B-lymphocyte receptors like BCR, FcR, CR, dectin-1, etc. 
activates the B cell to internalize the bacteria or if bacterial uptake is an active process trig-
gered by bacterial components, as is the case of products from the pathogenicity islands of 
Salmonella [77].
In phagocytic cells (macrophages, neutrophils, monocytes), phagocytosis can be divided into 
type I and type II phagocytosis [78]. Type I phagocytosis is mediated by Fc receptors which 
recognize targets opsonized by immunoglobulins, being the most important the receptors 
FcRγ that recognizes different subclasses of IgG bound to the pathogen. Interaction between 
FcγR and IgG triggers phosphorylation of specific tyrosine residues in the ITAM-type motifs 
present in the intracellular domain of FcγR [79]. Later, the recruitment and activation of sig-
naling proteins belonging to the Rho GTPases family, like Cdc42, resulting in actin polymer-
ization, membrane protrusion formation, and bacterial internalization occur [80].
In the phagocytosis type II, particles opsonized by several complement fractions (like C3b 
and iC3b) are recognized by cells that have complement receptors CR1 and CR3 (CD11b), 
like macrophages or neutrophils. Complement-opsonized particles “sink” into the phagocyte; 
membrane disturbance is minimal without long membrane protrusion formation; particle 
internalization does not usually lead to an inflammatory response or oxidative burst. In this 
case, the small GTPase molecule activated is the GTPase RhoA, and they do not necessarily 
involve Cdc42 and Rac; after GTPase activation, the remodeling of the membrane driven by 
filamentous actin, phagosome closure, and pathogen internalization occurs [78, 79, 81].
Up today there are few studies on B-cell capabilities for bacterial internalization; there are 
descriptions of B-cell internalization of opsonized bacteria with immunoglobulin and with 
complement [63, 69, 74], but also there are descriptions that B cells can uptake non-opsonized 
bacteria [72]; so far there are no studies that clarified the role of small GTPases involved in 
bacterial internalization by B cells that could help to clarify if bacterial uptake by B cells is a 
phagocytic type I or type II process or if it is a unique endocytic mechanism for B cells.
3.6.2. Clathrin-mediated endocytosis (CME)
Clathrin-mediated endocytosis is a well-known endocytic mechanism performed by many 
cells, is involved in the intake of extracellular molecules recognized by cell membrane receptors, 
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and is a major route of traffic from plasma membrane to endosomes [81, 82]. B cells recognize 
antigens by adaptive and innate mechanisms; the adaptive recognition is the most studied, also 
in the case for recognition of soluble antigens [83, 84]. Antigen adaptive recognition of B cells 
involves the antigen-specific B-cell receptor (BCR) expressed by B lymphocytes; BCR has two 
distinct tasks: the first one is to trigger cell activation after interaction with the specific antigen, 
and the second one is to internalize the antigen for subsequent processing and presentation on 
MHC class II molecules [85]. Clathrin is the scaffold of conserved cellular structures (pits) that 
are formed to capture membranal fractions where various cellular receptors are concentrated; 
once the ligand is bound to the membrane receptor, clathrin polymerization occurs resulting in 
a covered pit that detaches from the membrane as a coated vesicle that initiates an endosomal 
trafficking process [81, 82]. In B lymphocytes, clathrin-mediated endocytosis is a fundamen-
tal mechanism to translocate BCR-antigen complex to endosomal compartments; lipid rafts, 
microfilaments, and dynamin are required for this process [86, 87].
B lymphocytes can recognize bacterial antigens by their BCR, that is the case for Salmonella 
and Francisella pathogens. BCR-mediated internalization of Salmonella Typhimurium allowed 
bacterial internalization, antigen presentation into MHC class II molecules, and antibody 
production against Salmonella [88]. For the case of Francisella, evidence has demonstrated 
that Francisella is recognized by the B1-a cell by their BCRs alone; meanwhile, in the B1-b- 
and B2-cell subsets, bacterial recognition required simultaneous participation of BCR and 
complement receptors CR1 and CR2. F. tularensis was internalized by B cells at low rate, 
and internalized bacteria survive intracellularly [63]. In both studies the internalization pro-
cess resembled more a cell membrane protrusion formation mechanism (like phagocytosis 
or macropinocytosis) rather than a clathrin-coated endocytosis mechanism. The size of the 
clathrin-coated pits is around 120 nm, being too small for a bacteria to fit in; however, recent 
studies have demonstrated that other larger structures coated with clathrin (clathrin plates) 
[82] are also formed into the cells; it will be interesting to find if bacteria could be uptaken 
by this mechanism.
3.6.3. Macropinocytosis
Macropinocytosis is a type of pinocytosis described for Warren Lewis in 1931 [89]. Eukaryotic 
cells have the capacity to internalize fluid (pinocytosis) and particles (phagocytosis) from the 
extracellular environment, using a variety of different processes [81]. Micropinocytosis is a 
common process in all cells; this mechanism results in the formation of small vesicles coated 
with clathrin, caveolin, or other proteins; also clathrin- and caveolin-independent mechanisms 
exist [81, 90]. Internalization of larger volume of fluids is mediated by a process called macropi-
nocytosis; many signals trigger macropinocytosis, such as macrophage colony-stimulating fac-
tor-1 (CSF-1), epidermal growth factor (EGF), and phorbol myristate acetate [91]. Depending 
on the cell type, macropinocytosis can be a constitutive or an induced process. Macrophages 
and dendritic cells often utilize macropinocytosis to screen the extracellular environment for 
pathogenic or harmful materials [92]. Macropinocytosis is the main route for extracellular 
fluid uptake by the cells; it depends on energy and actin cytoskeleton rearrangements lead-
ing to the formation of filamentous and branched actin, supporting membrane modifications 
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and lamellipodia formation; actin polymerization is initiated by the activation of the small 
Rho GTPase family (Rho, Cdc42, and Rac) working in parallel with phosphoinositides, to acti-
vate the WASp/Scar proteins, and the Arp2/3 complex, allowing actin branching, that force 
out plasma membrane and form membrane ruffles [93]. Macropinosomes are formed when 
these ruffles collapse with the plasma membrane enclosing a large volume of extracellular 
fluid phase; macropinosomes are spacious vesicles within the cytoplasm that can reach a size 
>0.2 μm [81]. Some pathogens take advantage of the macropinocytosis mechanism to enter 
into the non-phagocytic cells; Shigella, Salmonella, and Mycobacterium are bacteria known to 
use this mechanism [94–97]. The internalization process is characterized by the formation of 
actin-rich membrane protrusions known also as ruffles; for that, Salmonella produces the type 
III secretion system (T3SS) that translocate effectors from the Salmonella pathogenicity island I 
(SPI) into the host cytosol; these virulence factors target host mediators involved in cytoskel-
eton rearrangements like Rac, Cdc42, phosphoinositides, Arp2/3 complex, etc., resulting in 
actin cytoskeleton rearrangements and membrane ruffling [94, 98]. In the process of ruffling 
formation, the pathogen is captured among the ruffles that finally enclose the bacteria into 
a spacious macropinosome [93]. B lymphocytes can also be infected by bacterial pathogens 
that enter the B cell through a mechanism of macropinocytosis; Salmonella, Francisella, and 
Mycobacterium are some of these pathogens [28, 72, 99]; so far there is not a detailed description 
of the characteristics of this process in B lymphocytes.
4. Bacterial infections of B lymphocytes
B lymphocytes are central cells of the immune response being responsible of antibody pro-
duction, but they are also cells that may modulate the immune response by the production of 
proinflammatory as well as anti-inflammatory cytokines [100, 101]. B lymphocytes can be the 
target of infection by various pathogens; the most recognized B infections are viral infections, 
especially infection caused by the Epstein-Barr virus (EBV). The susceptibility of B lympho-
cytes to this virus is primarily due to the expression of the CD21 molecule that is related to 
the gp350 viral protein [102]. In B lymphocytes EBV presents the lytic phase [103], while the 
latent phase of the virus is expressed in memory B lymphocytes [104]. B lymphocytes are also 
susceptible to viral infections caused by cytomegalovirus [105, 106] and smallpox virus [107, 
108], among others. Viral infections in B lymphocytes modify the lymphocyte response to 
allow viral multiplication or persistence, alter apoptosis processes, interfere with antigenic 
presentation, etc., all to promote viral survival [55].
Although virus was among the earliest recognized pathogens with infective capabilities 
toward lymphocytes, perhaps the classic concept that B lymphocytes lacked phagocytic capa-
bilities did not allow the recognition of bacterial infections in these cells [88, 109]. However, at 
present it is known that lymphocytes can internalize bacterial pathogens (mainly intracellular) 
and that these infections trigger different B-cell responses. Among the bacterial pathogens rec-
ognized with capacity to infect B lymphocytes are the genera: Salmonella, Brucella, Francisella, 
Moraxella, Mycobacterium, etc. Some characteristics of such infections will be described.
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4.1. Moraxella B-cell infection
Moraxella catarrhalis is a Gram-negative bacterium that causes respiratory infections in chil-
dren and causes chronic lung disease in adults; in children, it is highly associated with ear 
infections [110, 111]. M. catarrhalis produces the superantigen Moraxella IgD (MID)-binding 
protein, which binds to B-lymphocyte IgD, inducing lymphocyte proliferation, but cell pro-
liferation requires also engagement of the innate TLR receptors [112]. In the particular case 
of M. catarrhalis, TLR-9 is required for B-lymphocyte proliferation; TLR-9 recognizes CpG 
motifs, distinctive of DNA of bacterial or viral origin [113]. The tonsil B lymphocytes are able 
to internalize M. catarrhalis by receptor-mediated endocytosis and after some time eliminate 
the internalized bacteria [112]. However, it has been described that M. catarrhalis is able to 
persist in pharyngeal lymphoid tissue including the adenoids and the tonsils, residing in 
macrophages and B lymphocytes [114].
4.2. Brucella B-cell infection
Among facultative intracellular microorganisms, Brucella spp. is one of the most representa-
tives; this bacterium causes infections that become persistent in both humans and animals, 
representing a global zoonosis [115]. Brucella persists and replicates primarily in tissues 
and cells of the mononuclear phagocytic system, such as the spleen, bone marrow, lymph 
nodes, spleen, macrophages, and dendritic cells, and may also reside in cells of male and 
female reproductive systems including the uterus, placenta, and ovaries [116]; however, it has 
recently been recognized that B lymphocytes are not only infected but function as a reservoir 
of these bacteria [69]. Brucella also invades non-phagocytic cells such as epithelial cells, and 
the mechanism of internalization has been reported as zipper-like, promoting cytoskeleton 
rearrangement through the activation of Cdc42 by the pathogenic strains of B. abortus [117]. 
Brucella internalization into B cells depends on microfilaments and once internalized is allo-
cated into late endosomal/lysosomal compartment allowing bacterial persistence and resi-
dency, infected B lymphocyte, thus producing anti-inflammatory cytokines such as TGF-β; 
interestingly mice lacking of B cell are more resistant to Brucella infection, pointing an impor-
tant role of B cells as immunomodulators toward brucellosis [69].
4.3. Francisella B-cell infection
Francisella (especially F. tularensis) is another bacterium able to internalize and invade B 
lymphocytes; this bacterium is a facultative intracellular pathogen and has been reported 
that it infects phagocytic cells like macrophages, neutrophils [118, 119], and pulmonary 
and hepatic non-phagocytic cells [120, 121], among others. The main host cells of F. tular-
ensis are the macrophages, where once the bacterium is internalized, it inhibits phagolyso-
somal fusion and leaves the cytoplasm, where it resides and actively replicates [122–124]. 
Francisella-infected macrophages promote a systemic anti-inflammatory reaction with high 
levels of TGF-β [125], with fatal consequences for the infected individual [126]. The first 
studies that highlighted the involvement of B lymphocytes in F. tularensis infection date 
back to the late 1990s, where it was found that B cells rather than antibodies were critical for 
protection against this bacterium [127].
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The infective abilities of F. tularensis toward B lymphocytes were described in 2008, and it 
was found that the bacterium could be readily internalized by primary B lymphocytes and 
by B lymphocyte cell lines like Ramos or A20; lymphocytes allowed a moderate intracellular 
multiplication by 24 h after infection; however, from this time infected lymphocytes began to 
undergo apoptosis, which was accentuated at 48 h postinfection [128].
Among the B-lymphocyte (CD19+) subtypes, B1-a lymphocytes, classified as innate lympho-
cytes, are the best infected by F. tularensis, requiring only the BCR engagement for bacterial 
internalization, whereas B1-b and B2 lymphocytes are also susceptible to infection, although 
to a lesser extent; they require the joint participation of BCR and CR1/CR2 receptors for bac-
terial internalization [63]. B lymphocytes from mice infected with the live vaccine strain of 
F. tularensis (LVS), especially the B1-a lymphocytes uptake the bacteria; produce numerous 
proinflammatory cytokines such as IFN-γ, IL-1β, IL-12, IL-17, and TNF-α; decrease amounts 
of IL-10; and express costimulatory molecules like CD80 and CD86; mice were able to clear 
bacterial burden 10 days postinfection [129]. Recent studies confirm that the involvement of B 
lymphocytes is critical for the control of F. novicida infections [130] and that Francisella inter-
nalization into B cells requires cell membrane integrity [63].
4.4. Salmonella B-cell infection
The role of B lymphocytes among the bacterial infections has been studied the most for the 
case of Salmonella infection, and the evidences demonstrate the importance of these cells in 
the pathogenesis of diseases caused by this bacterial genus. Infections caused by Salmonella 
genus can be differentiated into two types: typhoid and non-typhoid. Gastroenteritis are 
caused by non-typhoidal serovars such as Salmonella enterica serovar Typhimurium, S. enterica 
serovar Enteritidis, and S. enterica serovar Newport, while the enteric fever is caused by 
typhoidal Salmonella serovars like Salmonella enteritidis serovar Typhi and S. enteritidis 
serovar Paratyphi [131]. The infection caused by S. Typhimurium in mouse is very simi-
lar to that caused by Salmonella Typhi in the human, and much of the knowledge of this 
infection is due to studies in the murine model with S. Typhimurium [132]. Salmonella are 
facultative intracellular pathogens; both serovars share many virulence factors (flagella, 
lipopolysaccharide, and pathogenicity islands) but differ in clinical manifestations: typhoid 
fever occurs within 2 weeks and has systemic manifestations, and gastroenteritis occurs in 
a shorter period (12–72 h), with a rapid accumulation of neutrophils at the intestinal level 
[133]. After S. enterica enters the organism orally, it is rapidly captured by the epithelial 
cells of the intestine and M cells and after a few hours is found in the lamina propria of 
the intestine and in the Peyer’s plaques [134]. Already in the intestinal tissue, Salmonella 
is internalized by various phagocytic cell types such as macrophages, dendritic cells, and 
neutrophils [135], and it has been suggested that Salmonella is internalized also by B lym-
phocytes, which are abundant in Peyer’s plaques adjacent to intestinal M cells [43, 136]. 
Salmonella epithelial cell invasion is an active process triggered by the bacterium, in which 
cell cytoskeleton rearrangements OCCUR,  resulting in the formation of membranal protru-
sions that allow bacterial internalization, a phenomenon known as macropinocytosis [137]; 
Salmonella has developed very specialized systems to promote this event, within these is the 
type III secretion system (TTSS), through which the bacteria injects to the host cell  products 
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derived from the pathogenicity islands I and 2 (SPI1, SPI2) [138], which promote the acti-
vation of Rho, Rac, and Cdc42 small GTPases, thus favoring cytoskeletal remodeling and 
stimulating the production of caspase-1 which catalytically activates proinflammatory cyto-
kines such as IL-1β and IL -18 [133]. Once internalized, Salmonella resides intracellularly 
in membranes called Salmonella-containing vacuole (SCV), which protects the bacteria by 
avoiding fusion with lysosomes and avoiding the reactivity of reactive oxygen metabolites 
[139, 140]. Salmonella can infect several cell types, from macrophage and dendritic cells to 
non-phagocytic like epithelial cells and hepatocytes [141]. Salmonella can be internalized 
in and infect B lymphocytes [43]. Evidence has shown that Salmonella is internalized into 
B lymphocytes through a macropinocytosis process [72, 73]. Bacterial recognition by B 
cells is also required for internalization; Salmonella may be recognized by BCR [88], by TLR 
[142], or by products derived from SPI-1 [143]. Depending on the internalization mecha-
nism, Salmonella survival will occur, for instance, bacteria opsonized with complement or 
internalized by a mechanism triggered by products of the SPI-1 survive a replicate few 
hours after internalization, whereas bacteria opsonized with IgG or not opsonized will be 
eliminated soon after internalization [139]. Once internalized, the bacterium resides in SCV 
vacuoles, which in the case of B lymphocytes allow the cross-presentation of the Salmonella 
antigens to major histocompatibility complex molecules class one (MHC-I), by the vacuolar 
or cytosolic pathways [144]. This cross-presentation would promote infected-B-cell recogni-
tion and elimination by CD8 + T lymphocytes; however, this elimination does not occur, 
and it has been described that in both B1 and B2 lymphocytes infected with Salmonella, 
the PD1-PD1L pathway (programmed death-1; programmed death-1 ligand) is expressed, 
resulting in a reduction in the signaling required for activation of the T-cell receptor (TCR) 
and consequently avoiding B-cell death [145–147]. One of the characteristics of Salmonella is 
its ability to persist, and the use of the PD1 system in B lymphocytes makes them an ideal 
niche for prolonged stay in the body.
Thus, B lymphocytes play a key role in Salmonella infections, functioning as bacteria reser-
voir, acting as immunoregulatory cell through IL-10 production [148], facilitating bacterial 
systemic dissemination [43], and promoting a proinflammatory intestinal state characteristic 
of non-typhoidal infections through the production of proinflammatory cytokines such as 
IL-1β [135].
4.5. Mycobacterium B-cell infection
The genus Mycobacterium comprises a large number of species, some of which are highly patho-
genic as Mycobacterium tuberculosis (MTB), being also the most studied species of all mycobac-
teria. MTB is a facultative intracellular pathogen; macrophages are the main cells where the 
mycobacteria reside and multiply [149], being able to infect other cells such as pulmonary epi-
thelial cells [93, 150], fibroblasts [151], adipocytes [152], or endothelial cells [153]; bacterial rep-
lication into the non-phagocytic cells is discrete, so they have been suggested as niches where 
the bacteria may persist. In mycobacterial infections, the protective response is cellular, medi-
ated by T helper (Th) lymphocytes and activated macrophages [154]. The involvement of anti-
bodies and B lymphocytes has recently begun to be recognized. For example, B lymphocytes 
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are required to control pulmonary inflammation and bacterial load [155] and antibodies and 
cytokine production by B lymphocytes mainly IL-10 and contribute to these activities [156]. 
Lymphocytes have been considered as non-phagocytic cells or with less interiorization capacity 
than macrophages [70, 71]. Mycobacteria promote their internalization in non-phagocytic cells, 
including B lymphocytes [72]. One way to establish the low phagocytic activity of B lympho-
cytes is to incubate them in the presence of inert particles like zymosan (Figure 4).
Macropinocytosis is an internalization process triggered by several inductors [157]; experi-
mentally, phorbol esters trigger macropinocytosis even in phagocytic cells [158]. Pathogens 
use this internalization mechanism to achieve their entry into cells, by producing factors that 
trigger cytoskeleton reorganization [93]; for the case of mycobacteria, our group has sug-
gested that pathogenic mycobacteria such as M. tuberculosis or nonpathogenic Mycobacterium 
smegmatis produce soluble factors present in the culture medium that trigger this phenom-
enon in B lymphocytes (Figure 5). Some of the reported mycobacterial products that facilitate 
adhesion and internalization into non-phagocytic cells are fibronectin-binding protein (FBP) 
and heparin-binding hemagglutinin adhesin (HBHA) [159, 160], among others [161, 162]. The 
internalization of mycobacteria in immortalized B lymphocytes (cell lines) has been described 
by some authors [72, 74, 163]; these studies show that M. tuberculosis survives and multiplies 
intracellularly in B lymphocytes, and as a consequence of infection, there is lymphocyte acti-
vation, resulting in antibody production of IgM class mainly and expression of co-stimulatory 
molecules like CD80 and CD86 [74]. There are scarce studies on human in vivo B-lymphocyte 
infection [164], so establishing the precise involvement of B lymphocytes in mycobacterial 
infections is an area of great interest.
Figure 4. Is the B cell a “phagocytic cell”? B cells from the Raji cell line were incubated with zymosan without any further 
treatment, during 3 h; then cells were fixed with paraformaldehyde and stained with Giemsa dye. Control cells: cells did 
not receive any treatment. Zymosan only: cells were incubated with zymosan without any treatment. Zymosan and MTB 
SN: cells were incubated with zymosan and Mycobacterium tuberculosis filtrated growth bacterial culture medium (0.22 mm) 
for complete removal of the bacteria. Zymosan only: zymosan particles were observed bound to B-cell membrane; 3 h after, 
zymosan was not observed into the B cells. Zymosan + MTB SN: culture medium collected after 2 weeks of incubation at 
37°C was placed with B lymphocyte; more zymosan particles were observed bound to B cell; after one h it was possible to 
observe intracellular zymosan.
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Figure 5. B-cell membrane changes after 1 h of incubation with PMA or mycobacteria derivatives. Scanning electron 
microscopy (SEM) and fluorescence microscopy images of Raji B cells. (Panel a) Control cells. (Panel b) Cells treated 
with phorbol-myristate-acetate (PMA), a classical macropinocytosis inductor. (Panel c) Cells treated with filtrated 
supernatant from growth culture medium of Mycobacterium smegmatis. (Panel d) Cells infected with Mycobacterium 
tuberculosis. Fluorescence images correspond to actin cytoskeleton labeled with phalloidin rhodamine. SEM images were 
17,000× (panels a and d) or 15,000× (panels b and c); all fluorescence images were observed at 1200×.
5. Implications of B-cell response in bacterial infections
B lymphocytes are involved in various stages of the immune response against pathogens; the 
traditional role of these cells has been associated with adaptive immune response, characterized 
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by the production of antibodies and the generation of immune memory. In bacterial infection, 
the role of these cells in the innate response has recently been recognized; in this sense, it has 
been demonstrated that B cells express receptors capable to recognize bacterial structures (TLRs, 
CR, dectin-1, etc.) [55, 165–167] and produce the effectors of the immune response—cytokines 
and antimicrobial peptides [168–171]—also activating mechanisms that prompt pathogen con-
trol like nitric oxide (NO) and antimicrobial peptides, among other [168]. The immune response 
induced in B lymphocytes often depends on the type of pathogen and the way in which B cell is 
activated, so B-cell response may be regulated by the bacteria to favor its intracellular survival. 
The B lymphocytes possess an endocytic capability that allows them to internalize pathogens; 
the mechanisms that these cells use to internalize bacteria can be endocytosis dependent or 
independent of clathrin, macropinocytosis, phagocytosis, etc. [72, 73, 88, 88, 168, 172]. As a result 
of this internalization, B lymphocytes produce a series of mediators of the innate response that 
will be described.
5.1. Cytokines
B cells recognize pathogens in an infectious process through the BCR or PRR receptors; this 
recognition may induce the cell activation and the production of inflammatory cytokines such 
as IL-1, IL-6, IL-8, TNFα, and IFNγ and suppressor cytokines as IL-10 and transforming growth 
factor beta (TGF-β), in addition to participating in Th2 profile events characterized by the pro-
duction of IL-4, IL-5, IL-13, granulocyte-colony stimulating factor (GCSF), and granulocyte-
macrophage colony-stimulating factor (GMCSF). B-cell plasticity is so extensive that any of 
these profiles can be induced by B cells depending on how they are activated [173–176].
Although B cells can show an inflammatory profile in response to bacterial infections, they 
cannot control infection at all times; some pathogens, especially intracellular ones, are able to 
occupy B cells as reservoirs of infection and can modulate the immune response of these cells 
to survive or even multiply within B lymphocytes. In the case of B-lymphocyte interaction 
with some Gram-negative bacteria such as Brucella abortus [69], M. catarrhalis [112, 166], and 
Salmonella spp [148, 177, 178], induce a high production of IL-10 which activates an immuno-
suppressive response characterized in addition by the simultaneous production of TGF-β, 
under this stage the bacteria rapidly spread. Listeria monocytogenes infection shows an IL-10-
producing B-cell profile at very early stages of infection, which promotes bacteria persistence 
and dissemination [179–181]. Another example of B lymphocyte-bacteria interaction is the 
infection caused by F. tularensis which in B cell (particularly B1-a subtype) induces a clearly 
inflammatory profile characterized by the production of IL1-b, IFNγ, IL-6, IL-12, IL-17, and 
TNF-α [128, 129]. Regarding the activation of the inflammasome complex in B cells infected 
with Salmonella, it has been described that although this system is functional in B cells, the 
IL1-β is not secreted because this bacterium inhibits its production by a mechanism of nega-
tive regulation of the NLRC4 protein, which favors bacterial intracellular persistence [182].
5.2. Nitric oxide (NO)
Nitric oxide is one of the important mediators of the immune response that plays a funda-
mental role in the elimination of pathogens. This molecule is produced by classical phagocytic 
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cells; however, its production has also been described by cells classified as non-phagocytic 
including B lymphocytes. During respiratory burst, NO in conjunction with the reactive oxy-
gen species (ROS) participates in the formation of peroxynitrites, which are highly oxidizing 
agents of many components of the bacteria. NO increases its expression and activity in B 
lymphocytes infected with intracellular pathogens such as M. tuberculosis, S. Typhimurium, 
and Citrobacter rodentium [183–185]. The subclass of B1 lymphocytes constitutively produces 
nitric oxide inducible synthase (iNOS); however, in infectious events this enzyme increases its 
expression levels and therefore its activity, such as the LBs infected with Cryptococcus neofor-
mans; in this infection, NO has a fundamental role in the elimination of the pathogen [186]. NO 
production in B1 lymphocytes appears to be linked to the stimulation of various TLRs, since 
some studies have shown that the stimulation of these receptors and their ligands resulted in 
production of higher NO levels by B lymphocytes. Of the Toll receptor ligands that have been 
studied, the major enhancer of NO expression was bacterial LPS; other agonists such as Poly 
I: C (TLR3), Imiquimod (TLR4), and CpG DNA (TLR9) also induce their expression [168, 187].
5.3. Antimicrobial peptides
Antimicrobial peptides are innate response effectors present in most human cells; these mole-
cules are classified into alpha-defensins (HNP1-6) beta-defensins (hBD 1-4), and cathelicidins 
such as LL37. Its mechanisms of action include the direct lysis of the microorganisms, the gen-
eration of a proinflammatory environment, or the modulation of the immune response. There 
are very few studies on B-lymphocyte expression of antimicrobial peptides; however, there 
are some evidences demonstrating that B cells express antimicrobial peptides in constitutive 
and inducible fashion; under stimulation with some PAMPS, B lymphocytes express alpha 
defensins (HNPs 1–3), hBD2, and the cathelicidin LL-37 [170, 188].
5.4. Reactive oxygen species
B cells participate actively in the control of microorganisms, and although many authors 
have considered them as non-phagocytic cells, it seems that these cells possess microbicidal 
capacities, since they are able to produce antibacterial mediators like ROS. The Nox fam-
ily of enzymes is responsible for regulating the production of ROS in several cell types like 
neutrophils and macrophages; the Nox2 isoform is particularly essential in the elimination 
of bacteria in these cells. Recently Nox2 production was described by splenic and peritoneal 
B lymphocytes; the absence in Nox2 production decreases the production of ROS resulting 
in a deficient elimination of Staphylococcus aureus by B lymphocytes; contrarily normal B cell 
controlled intracellular bacteria growth [171].
5.5. Regulation of B-cell survival during bacterial infection
The ability of several pathogens to regulate the death pathways of the host cell has been 
described for most of the pathogens that infect different cells, and actually this situation is 
recognized for B lymphocytes. For example, L. monocytogenes is known to induce apoptosis in B 
cells through various mechanisms such as activation of caspases 3, 8, and 9 [179, 189]. Apoptosis 
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induction during bacterial infection of B cells has been reported for F. tularensis, S. flexneri, 
and Helicobacter pylori [55, 128, 190]; in all three cases, apoptosis of B cells is a mechanism that 
can facilitate the survival and dissemination of pathogens in their host due to the death of B 
lymphocytes that could have a protective effect. In comparison, during B-cell infection with 
Salmonella, the bacteria promote B-cell survival by engaging different mediators like PD-1 [145] 
or through the negative regulation of the protein NLRC4 [182], avoiding in both cases cell 
death. In this way, B cell becomes an intracellular niche for bacterial survival, persistence, and 
dissemination; the bacteria have a major role in promoting this situation [43, 182].
6. Concluding remarks
B lymphocytes are fascinating cells, far beyond being precursors of plasma cells; they repre-
sent a heterogenic cell population with an ample range of activities; beside antibody synthe-
sis, they act as antigen-presenting cells; they produce pro- and anti-inflammatory cytokines 
acting as modulators of the immune response; and also they can uptake bacterial pathogens 
for latter processing and presenting them to T cells. Recent findings have left behind the old 
idea that B lymphocytes were not able to internalize bacterial or particulate antigens, but not 
all the B lymphocyte subsets have this ability. The B1-a subset is the major B-cell subset that 
is able to internalize bacterial pathogens; in the beginning, the antigen is recognized by PRRs 
like BCRs, TLRs, CRs, etc. After recognition, B cell will be activated, internalizing the bacteria, 
and depending on antigen´s nature (pathogenic or no pathogenic), the B lymphocyte will be 
activated to contribute in the establishment of a protective immune response. In some cases 
(specially for pathogenic bacteria), the B cell will not be able to control the pathogen; then the 
B cell becomes a pathogen niche or reservoir, acting as a “Trojan horse” that allows bacteria 
dissemination in the organism; in other cases, the pathogen modulates B-cell death, allowing 
cell and pathogen survival and making the B cell as an excellent host for bacterial persistence. 
The endocytic pathways performed by B lymphocytes to uptake bacteria, so far reported, are 
macropinocytosis and phagocytosis; still, there exists controversy regarding the ability of B 
lymphocyte to perform one, the other, or both mechanisms. It has been proposed that the B1-a 
cell subset has the double lineage lymphocyte/macrophage, making the B1-a cell prompt to 
respond to bacterial challenges and to respond to them in conjunction with the T cells; then 
these cells represent a bridge between the innate and the adaptive responses. Still, the B cells 
have many “secrets” that have to be revealed.
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